detrol la tolterodine tartrate 4 mg

1 INDICATIONS AND USAGE DETROL LA Capsules is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see CLINICAL STUDIES (14) ] . DETROL LA is an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 )

pharmacia and upjohn company llc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] alopecia` `[3] fatigue` `[4] pain` `[5] nausea` `[6] diarrhoea` `[7] headache` `[8] off label use` `[9] dyspnoea` `[10] vomiting`

1 year ago

CAPSULE BLUE logo 4

1 year ago

logo 4 CAPSULE BLUE

16 HOW SUPPLIED/STORAGE AND HANDLING DETROL LA capsules are supplied as follows: Bottles of 30 Bottles of 500 2 mg capsules NDC 0009-5190-01 2 mg capsules NDC 0009-5190-03 4 mg capsules NDC 0009-5191-01 4 mg capsules NDC 0009-5191-03 Bottles of 90 Unit Dose Blisters 2 mg capsules NDC 0009-5190-02 2 mg capsules NDC 0009-5190-04 4 mg capsules NDC 0009-5191-02 4 mg capsules NDC 0009-5191-04 Store at 20°–25°C (68°–77°F); excursions permitted to 15–30°C (59–86°F) [see USP Controlled Room Temperature]. Protect from light.

More pills like CAPSULE logo 4

Related Pills

detrol la tolterodine tartrate 4 mg

pharmacia and upjohn company llc

detrol la tolterodine tartrate 2 mg

pharmacia and upjohn company llc

Gabapentin gabapentin 600 MG Oral Tablet

Teva Pharmaceuticals USA Inc

Gabapentin gabapentin 800 MG Oral Tablet

Teva Pharmaceuticals USA Inc

ranolazine tablet film coated extended release

actavis pharma, inc.

raltegravir 100 MG Chewable Tablet Isentress

Merck Sharp & Dohme Corp.

raltegravir 25 MG Chewable Tablet Isentress

Merck Sharp & Dohme Corp.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site